ReviewCancers2019

Predictors of Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Receiving EGFR Tyrosine Kinase Inhibitors: A Systematic Review and Meta-Analysis.

Carlo Buonerba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.